Finally, in leukemia cells from two R/R FLT3 mutant patients clinically resistant to TKIs (Table 1), whose cells were resistant to gilteritinib in vitro, treatment with OTS167 was capable of inducing cell death (Fig. 5E). The gene discussed is FLT3; the disease is leukemia.